Tissue plasminogen activator levels change with plasma fibrinogen concentrations during pregnancy

被引:0
|
作者
J. Choi
S. Pai
机构
[1] Department of Clinical Pathology,
[2] College of Medicine,undefined
[3] Inha University Hospital,undefined
[4] 7–206,undefined
[5] 3-ga,undefined
[6] Shinheung-dong,undefined
[7] Jung-gu,undefined
[8] Inchon 400–103,undefined
[9] Republic of Korea,undefined
来源
Annals of Hematology | 2002年 / 81卷
关键词
Coagulation factors Fibrinogen Pregnancy Tissue plasminogen activator;
D O I
暂无
中图分类号
学科分类号
摘要
To investigate the relationship between coagulation activities and the fibrinolytic system during normal pregnancy, we measured the plasma concentrations of coagulation factors, antithrombin III (AT III), D-dimer, tissue plasminogen activator (tPA), total protein S (TPS), and plasminogen activator inhibitor type 1 (PAI-1) in 436 apparently healthy pregnant, postpartum, and nonpregnant women. There were no significant changes in AT III, TPS, and factor XI concentrations during pregnancy and puerperium. However, factor VII, VIII, IX, and XII activities increased gradually as pregnancy progressed, reached maximum values in the third trimester, and returned to nonpregnant levels by 5–8 weeks postpartum. Plasma D-dimer levels in the third trimester of pregnancy were 1.23±0.42 µg/ml, significantly higher than for the first trimester (0.34±0.16 µg/ml, P<0.01). The tPA antigen levels averaged 1.8-fold higher in the late third trimester than in the first trimester; the plasma fibrinogen concentrations averaged 1.6-fold higher in the late third trimester than in the first trimester. Compared to the peak values during pregnancy, tPA levels averaged 39.8% lower and plasma fibrinogen concentrations averaged 40.0% lower at 5–8 weeks postpartum. The tPA levels correlated strongly with the plasma fibrinogen concentrations (r=0.52, P<0.01). In short, this study shows that tPA levels change in parallel with plasma fibrinogen concentrations during and after normal pregnancy.
引用
收藏
页码:611 / 615
页数:4
相关论文
共 50 条
  • [21] Local Cerebral Recombinant Tissue Plasminogen Activator Concentrations During Acute Stroke
    Essig, Fabian
    Kollikowski, Alexander M.
    Muellges, Wolfgang
    Stoll, Guido
    Haeusler, Karl Georg
    Schuhmann, Michael K.
    Pham, Mirko
    JAMA NEUROLOGY, 2021, 78 (05) : 615 - 617
  • [22] PLASMA TISSUE PLASMINOGEN-ACTIVATOR LEVELS IN PATIENTS WITH MYOCARDIAL-ISCHEMIA
    KOMAMURA, K
    HIRAYAMA, A
    ASADA, S
    SATO, H
    NAKATANI, S
    MASUYAMA, T
    NANTO, S
    NAKA, M
    KODAMA, K
    JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1987, 51 (07): : 742 - 743
  • [23] No influence of proinsulin and insulin on plasma levels of plasminogen activator inhibitor type 1 and tissue plasminogen activator in young women before and during intake of contraceptive steroids
    Petersen, KR
    Kjems, LL
    Skouby, SO
    Andersen, LF
    Jespersen, J
    METABOLISM-CLINICAL AND EXPERIMENTAL, 1996, 45 (07): : 833 - 837
  • [24] TISSUE-TYPE PLASMINOGEN-ACTIVATOR CONCENTRATIONS IN PLASMA FROM PATIENTS WITH PSORIASIS
    GRONDAHLHANSEN, J
    OTTEVANGER, V
    ACTA DERMATO-VENEREOLOGICA, 1989, 69 (05) : 391 - 394
  • [25] Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 antigen levels correlate with transplant coronary artery disease
    Warshofsky, MK
    Wasserman, HS
    Wang, WZ
    Teng, P
    Schwartz, A
    Rabbani, LE
    CIRCULATION, 1996, 94 (08) : 650 - 650
  • [26] Successful treatment of acute myocardial infarction during pregnancy with tissue plasminogen activator
    Schumacher, B
    Belfort, MA
    Card, RJ
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1997, 176 (03) : 716 - 719
  • [27] Plasma von Willebrand factor, tissue plasminogen activator, plasminogen activator inhibitor, and antithrombin III levels in Behcet's disease
    Ozoran, K
    Duzgun, N
    Gurler, A
    Tutkak, H
    Tokgoz, G
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1995, 24 (06) : 376 - 382
  • [28] Haemostatic factors and risk of coronary artery disease - Fibrinogen, tissue plasminogen activator and plasminogen activator inhibitor 1
    Kirschstein, W
    Scherhag, A
    Staedt, U
    Dempfle, CE
    Keller, H
    MEDIZINISCHE WELT, 1996, 47 (09): : 385 - 393
  • [29] NEW FRAGMENTS OF FIBRINOGEN WITH GREATER STIMULATION OF PLASMINOGEN CLEAVAGE BY TISSUE PLASMINOGEN-ACTIVATOR
    JEREMIAH, J
    SCHRIER, JA
    RAO, JR
    AMPHLETT, CW
    THROMBOSIS AND HAEMOSTASIS, 1985, 54 (01) : 43 - 43
  • [30] EVIDENCE OF ACTIVE AND INACTIVE COMPLEXES - TISSUE PLASMINOGEN-ACTIVATOR PLASMINOGEN IMMOBILIZED FIBRINOGEN
    MIRSHAHI, M
    SORIA, J
    HE, L
    SORIA, C
    SAMAMA, M
    CAEN, JP
    BIOCHEMISTRY, BIOLOGICAL FUNCTIONS, GENE REGULATION AND EXPRESSION, 1988, 801 : 175 - 180